MULTIDISCIPLINARY TEAM MEETING IN DIGESTIVE CANCERS: “A 6-YEAR EXPERIENCE IN AN ALGERIAN REFERENCE CANCER CENTER”
Author(s)
Kamel Bentabak, MD1, Mohammed Oukkal, MD2, djihad belarbi, MD3, sara Ouzit, MD4, Karim Cherchar, MD1, Chafik Bouzid, MD1, Zaki Boudiaf, MD5, Mohand Kheloufi, MD5, Ghozlane Bahbouh, PhD, MD5, aissam chibane, MD5, Hatem Boutekedjiret, MD5, Lamine Mahi, PhD, MD6, Rahima AMAROUCHE, PhD, MD7, Lamia Mouhoubi, PhD, MD7, Hassan mahfouf, PhD, MD8, Said BELHADEF, PhD, MD8, Arezki Arab, MD8, nabil debzi, MD9, nawel Afredj, MD10, Nawal Guessab, MD11, Rafik Kerbouche, MD12, Cherifa Sedkaoui, MD13, Sid Ahmed Faraoun, MD14;
1Department of Oncologic Surgery and Liver Transplantation, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Algiers, Algeria, 2CHU Beni Messous, ALGIERS, Algeria, 3Department of Medical Oncology, CHU Béni-Messous, Algiers – Algeria, Alger, Algeria, 4Department of Medical Oncology, CHU Béni-Messous, Algiers – Algeria, Algiers, Algeria, 5Department of Oncologic Surgery and Liver Transplantation, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Alger, Algeria, 6AXELYS SANTE, Algiers, Algeria, 7Department of Medical Oncology, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Alger, Algeria, 8Department of Medical Oncology, EPH Rouiba, Algiers – Algeria, Alger, Algeria, 9N. Debzi Department of Hepatology, CHU Mustapha, Algiers – Algeria , Alger, Algeria, 10 Department of Hepatology, CHU Mustapha, Algiers – Algeria , Alger, Algeria, 11Department of Hepatology, CHU Mustapha, Algiers – Algeria , Alger, Algeria, 12Department of Hepatology, CHU Mustapha, Algiers – Algeria, Alger, Algeria, 13C. Sedkaoui Department of Medical Oncology, CLCC Draa Benkhedda, Tizi-Ouzou – Algeria, Tizi Ouzou, Algeria, 14Department of Medical Imaging, CHU Bab El Oued, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Alger, Algeria
1Department of Oncologic Surgery and Liver Transplantation, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Algiers, Algeria, 2CHU Beni Messous, ALGIERS, Algeria, 3Department of Medical Oncology, CHU Béni-Messous, Algiers – Algeria, Alger, Algeria, 4Department of Medical Oncology, CHU Béni-Messous, Algiers – Algeria, Algiers, Algeria, 5Department of Oncologic Surgery and Liver Transplantation, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Alger, Algeria, 6AXELYS SANTE, Algiers, Algeria, 7Department of Medical Oncology, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Alger, Algeria, 8Department of Medical Oncology, EPH Rouiba, Algiers – Algeria, Alger, Algeria, 9N. Debzi Department of Hepatology, CHU Mustapha, Algiers – Algeria , Alger, Algeria, 10 Department of Hepatology, CHU Mustapha, Algiers – Algeria , Alger, Algeria, 11Department of Hepatology, CHU Mustapha, Algiers – Algeria , Alger, Algeria, 12Department of Hepatology, CHU Mustapha, Algiers – Algeria, Alger, Algeria, 13C. Sedkaoui Department of Medical Oncology, CLCC Draa Benkhedda, Tizi-Ouzou – Algeria, Tizi Ouzou, Algeria, 14Department of Medical Imaging, CHU Bab El Oued, Pierre and Marie Curie Cancer Center, Algiers – Algeria, Alger, Algeria
OBJECTIVES: Multidisciplinary team meetings (MDTs) are a cornerstone in oncology, ensuring evidence-based decision-making. This work aimed to describe and assess MDT activity of one of the largest oncology referral centers in Algeria.
METHODS: We conducted a retrospective descriptive analysis of MDT reports from 2017 to 2023. The meetings were held at the department of surgical oncology at the Centre Pierre et Marie Curie (CPMC), Mustapha Hospital, Algiers, and involved cases from five oncology centers of Bab El Oued, Béni Messous, Mustapha, Rouiba, and Tizi Ouzou. Data were anonymized and included patient demographics, tumor characteristics, metastatic status, and therapeutic decisions.
RESULTS: A total of 2,611 MDT reports were identified, corresponding to 1,938 patients. There were a slight majority of men (56%) and an average age of diagnosis of 59.9 years. Patients were referred from the wilayas (provinces) of Algiers (61%) and Tizi Ouzou (11%), consistently with the geographical location of the center. The most frequent localization was Left colon (43.1%), followed by rectum (21.41%), liver (14.9%) and pancreas (5.3%). Overall, 60% of patients displayed metastases, including liver (71%), lung (11%) and peritoneum (10%). Most patients had a single metastatic site (82%). MDT's decisions were mostly conclusive and led to a treatment proposal (68%) that was as follows: drug treatment in 36% of cases and surgery in 23% and less frequently interventional radiology, radiofrequency, radiotherapy or endoscopy. All therapeutic decisions were reached either in first (74.2%), second (18.2%) or third (7.5%) MDTs highlighting consistent alignment and comprehensive consideration of all therapeutic options.
CONCLUSIONS: This analysis provides a comprehensive overview of MDT functioning in one of the largest referral oncology center in Algeria. MDTs played a central role in treatment planning, particularly for colorectal cancer with liver metastases. Strengthening MDT processes may optimize patient outcomes and alignment with international guidelines.
METHODS: We conducted a retrospective descriptive analysis of MDT reports from 2017 to 2023. The meetings were held at the department of surgical oncology at the Centre Pierre et Marie Curie (CPMC), Mustapha Hospital, Algiers, and involved cases from five oncology centers of Bab El Oued, Béni Messous, Mustapha, Rouiba, and Tizi Ouzou. Data were anonymized and included patient demographics, tumor characteristics, metastatic status, and therapeutic decisions.
RESULTS: A total of 2,611 MDT reports were identified, corresponding to 1,938 patients. There were a slight majority of men (56%) and an average age of diagnosis of 59.9 years. Patients were referred from the wilayas (provinces) of Algiers (61%) and Tizi Ouzou (11%), consistently with the geographical location of the center. The most frequent localization was Left colon (43.1%), followed by rectum (21.41%), liver (14.9%) and pancreas (5.3%). Overall, 60% of patients displayed metastases, including liver (71%), lung (11%) and peritoneum (10%). Most patients had a single metastatic site (82%). MDT's decisions were mostly conclusive and led to a treatment proposal (68%) that was as follows: drug treatment in 36% of cases and surgery in 23% and less frequently interventional radiology, radiofrequency, radiotherapy or endoscopy. All therapeutic decisions were reached either in first (74.2%), second (18.2%) or third (7.5%) MDTs highlighting consistent alignment and comprehensive consideration of all therapeutic options.
CONCLUSIONS: This analysis provides a comprehensive overview of MDT functioning in one of the largest referral oncology center in Algeria. MDTs played a central role in treatment planning, particularly for colorectal cancer with liver metastases. Strengthening MDT processes may optimize patient outcomes and alignment with international guidelines.
Conference/Value in Health Info
2026-05, ISPOR 2026, Philadelphia, PA, USA
Value in Health, Volume 29, Issue S6
Code
EPH206
Topic
Epidemiology & Public Health
Topic Subcategory
Disease Classification & Coding
Disease
SDC: Oncology